Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 66.32x is 67% above its estimated 2-year average of 39.77x, near the low end of its estimated 2-year range (0.82x–487.23x).
As of 2026-10-06T15:13:02.489Z. 3.03% below its estimated 12-month average of 68.39x.
Calculation as of: 2026-10-06T15:13:02.489Z.
Quote observation: 2026-10-06T15:10:19.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85bde4aa0a662304b106d2bd805683c4a4a85ed0eecab472c1d88190f6ac555e
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
66.32x
EV/SALES RATIO AVG TTM
68.39x
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.03%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.17x
median of 424 covered companies
CURRENT VS SECTOR MEDIAN
+1490.41%
vs the sector median at left
Maze Therapeutics, Inc.
Market Cap
$1.47B
EV/Sales Ratio
66.32x
TTM Avg
68.39x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.46B
EV/Sales Ratio
0.71x
TTM Avg
0.73x
3Y Avg
0.58x
5Y Avg
0.61x
Market Cap
$1.50B
EV/Sales Ratio
1.47x
TTM Avg
1.67x
3Y Avg
1.40x
5Y Avg
1.32x
Market Cap
$1.51B
EV/Sales Ratio
14.35x
TTM Avg
10.18x
3Y Avg
7.41x
5Y Avg
6.19x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | $1.47B | 66.32x | 68.39x | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 0.71x | 0.73x | 0.58x | 0.61x |
| Certara, Inc. (CERT)vs › | $1.48B | 3.88x | 3.18x | 5.10x | 7.42x |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| GH Research PLC (GHRS)vs › | $1.49B | N/A | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 6.65x | 6.81x | 12.09x | 18.83x |
| Phibro Animal Health Corporation (PAHC)vs › | $1.50B | 1.47x | 1.67x | 1.40x | 1.32x |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.51B | 14.35x | 10.18x | 7.41x | 6.19x |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.42B | N/A | N/A | N/A | N/A |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.41B | N/A | 781.47x | 902.36x | 638.00x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 70.85x |
| 2026-10-02 | 70.85x |
| 2026-10-01 | 71.50x |
| 2026-09-30 | 73.06x |
| 2026-09-29 | 72.59x |
| 2026-09-28 | 72.09x |
| 2026-09-25 | 69.73x |
| 2026-09-24 | 70.20x |
| 2026-09-23 | 75.75x |
| 2026-09-22 | 76.60x |
| 2026-09-21 | 58.93x |
| 2026-09-18 | 59.32x |
| 2026-09-17 | 62.03x |
| 2026-09-16 | 63.45x |
| 2026-09-15 | 64.36x |
| 2026-09-14 | 65.66x |
| 2026-09-11 | 65.45x |
| 2026-09-10 | 66.10x |
| 2026-09-09 | 65.40x |
| 2026-09-08 | 70.68x |
| 2026-09-04 | 70.20x |
| 2026-09-03 | 69.20x |
| 2026-09-02 | 71.71x |
| 2026-09-01 | 71.15x |
| 2026-08-31 | 71.27x |
| 2026-08-28 | 73.83x |
| 2026-08-27 | 77.25x |
| 2026-08-26 | 80.14x |
| 2026-08-25 | 82.62x |
| 2026-08-24 | 80.20x |
| 2026-08-21 | 79.70x |
| 2026-08-20 | 78.23x |
| 2026-08-19 | 80.65x |
| 2026-08-18 | 78.82x |
| 2026-08-17 | 75.34x |
| 2026-08-14 | 73.06x |
| 2026-08-13 | 74.51x |
| 2026-08-12 | 74.10x |
| 2026-08-11 | 66.72x |
| 2026-08-10 | 66.64x |
| 2026-08-07 | 70.33x |
| 2026-08-06 | 70.01x |
| 2026-08-05 | 68.07x |
| 2026-08-04 | 67.53x |
| 2026-08-03 | 66.77x |
| 2026-07-31 | 65.67x |
| 2026-07-30 | 67.58x |
| 2026-07-29 | 66.61x |
| 2026-07-28 | 68.26x |
| 2026-07-27 | 70.44x |
| 2026-07-24 | 67.72x |
| 2026-07-23 | 67.74x |
| 2026-07-22 | 69.90x |
| 2026-07-21 | 72.08x |
| 2026-07-20 | 69.58x |
| 2026-07-17 | 68.90x |
| 2026-07-16 | 66.34x |
| 2026-07-15 | 72.32x |
| 2026-07-14 | 73.65x |
| 2026-07-13 | 71.76x |
| 2026-07-10 | 75.50x |
| 2026-07-09 | 80.49x |
| 2026-07-08 | 79.33x |
| 2026-07-07 | 81.62x |
| 2026-07-06 | 80.30x |
| 2026-07-02 | 77.36x |
| 2026-07-01 | 73.46x |
| 2026-06-30 | 73.54x |
| 2026-06-29 | 71.27x |
| 2026-06-26 | 69.74x |
| 2026-06-25 | 65.94x |
| 2026-06-24 | 64.99x |
| 2026-06-23 | 64.29x |
| 2026-06-22 | 62.03x |
| 2026-06-18 | 62.33x |
| 2026-06-17 | 60.06x |
| 2026-06-16 | 57.42x |
| 2026-06-15 | 58.53x |
| 2026-06-12 | 57.93x |
| 2026-06-11 | 58.04x |
| 2026-06-10 | 56.88x |
| 2026-06-09 | 57.61x |
| 2026-06-08 | 56.67x |
| 2026-06-05 | 58.53x |
| 2026-06-04 | 61.57x |
| 2026-06-03 | 60.12x |
| 2026-06-02 | 58.58x |
| 2026-06-01 | 61.73x |
| 2026-05-29 | 64.43x |
| 2026-05-28 | 64.27x |
| 2026-05-27 | 63.32x |
| 2026-05-26 | 64.13x |
| 2026-05-22 | 62.60x |
| 2026-05-21 | 62.52x |
| 2026-05-20 | 60.58x |
| 2026-05-19 | 59.04x |
| 2026-05-18 | 59.15x |
| 2026-05-15 | 62.00x |
| 2026-05-14 | 64.35x |
| 2026-05-13 | 65.78x |
| 2025-11-06 | 423.91x |
| 2025-11-05 | 435.13x |
| 2025-11-04 | 472.85x |
| 2025-11-03 | 487.23x |
| 2025-10-31 | 481.44x |
| 2025-10-30 | 486.88x |
| 2025-10-29 | 452.50x |
| 2025-10-28 | 467.23x |
| 2025-10-27 | 447.94x |
| 2025-10-24 | 437.24x |
| 2025-10-23 | 428.64x |
| 2025-10-22 | 414.96x |
| 2025-10-21 | 421.98x |
| 2025-10-20 | 426.01x |
| 2025-10-17 | 391.98x |
| 2025-10-16 | 403.21x |
| 2025-10-15 | 417.42x |
| 2025-10-14 | 404.09x |
| 2025-10-13 | 405.32x |
| 2025-10-10 | 385.32x |
| 2025-10-09 | 408.65x |
| 2025-10-08 | 405.84x |
| 2025-10-07 | 392.86x |
| 2025-10-06 | 386.90x |
| 2025-10-03 | 379.71x |
| 2025-10-02 | 369.01x |
| 2025-10-01 | 356.90x |
| 2025-09-30 | 359.01x |
| 2025-09-29 | 346.20x |
| 2025-09-26 | 377.78x |
| 2025-09-25 | 366.38x |
| 2025-09-24 | 363.39x |
| 2025-09-23 | 340.59x |
| 2025-09-22 | 319.37x |
| 2025-09-19 | 306.56x |
| 2025-09-18 | 316.03x |
| 2025-09-17 | 316.39x |
| 2025-09-16 | 315.68x |
| 2025-09-15 | 312.00x |
| 2025-09-12 | 312.88x |
| 2025-09-11 | 339.19x |
| 2025-09-10 | 185.18x |
| 2025-09-09 | 190.80x |
| 2025-09-08 | 166.77x |
| 2025-09-05 | 182.73x |
| 2025-09-04 | 167.99x |
| 2025-09-03 | 170.63x |
| 2025-09-02 | 172.91x |
| 2025-08-29 | 158.35x |
| 2025-08-28 | 154.49x |
| 2025-08-27 | 147.47x |
| 2025-08-26 | 150.63x |
| 2025-08-25 | 137.65x |
| 2025-08-22 | 140.81x |
| 2025-08-21 | 136.25x |
| 2025-08-20 | 140.63x |
| 2025-08-19 | 140.10x |
| 2025-08-18 | 138.35x |
| 2025-08-15 | 140.98x |
| 2025-08-14 | 138.35x |
| 2025-08-13 | 142.74x |
| 2025-08-12 | 1.99x |
| 2025-08-11 | 1.92x |
| 2025-08-08 | 1.83x |
| 2025-08-07 | 1.88x |
| 2025-08-06 | 2.12x |
| 2025-08-05 | 2.19x |
| 2025-08-04 | 2.38x |
| 2025-08-01 | 2.29x |
| 2025-07-31 | 2.25x |
| 2025-07-30 | 2.45x |
| 2025-07-29 | 2.51x |
| 2025-07-28 | 2.67x |
| 2025-07-25 | 2.79x |
| 2025-07-24 | 2.70x |
| 2025-07-23 | 3.01x |
| 2025-07-22 | 2.83x |
| 2025-07-21 | 2.75x |
| 2025-07-18 | 3.05x |
| 2025-07-17 | 2.86x |
| 2025-07-16 | 2.65x |
| 2025-07-15 | 2.58x |
| 2025-07-14 | 2.51x |
| 2025-07-11 | 2.33x |
| 2025-07-10 | 2.49x |
| 2025-07-09 | 2.34x |
| 2025-07-08 | 2.33x |
| 2025-07-07 | 1.57x |
| 2025-07-03 | 1.40x |
| 2025-07-02 | 1.50x |
| 2025-07-01 | 1.45x |
| 2025-06-30 | 1.61x |
| 2025-06-27 | 1.57x |
| 2025-06-26 | 1.73x |
| 2025-06-25 | 1.38x |
| 2025-06-24 | 1.10x |
| 2025-06-23 | 1.20x |
| 2025-06-20 | 1.32x |
| 2025-06-18 | 1.34x |
| 2025-06-17 | 1.64x |
| 2025-06-16 | 1.88x |
| 2025-06-13 | 1.90x |
| 2025-06-12 | 1.94x |
| 2025-06-11 | 1.74x |
| 2025-06-10 | 1.76x |
| 2025-06-09 | 1.75x |
| 2025-06-06 | 1.78x |
| 2025-06-05 | 1.88x |
| 2025-06-04 | 2.02x |
| 2025-06-03 | 1.97x |
| 2025-06-02 | 1.56x |
| 2025-05-30 | 1.01x |
| 2025-05-29 | 1.58x |
| 2025-05-28 | 1.40x |
| 2025-05-27 | 1.33x |
| 2025-05-23 | 1.08x |
| 2025-05-22 | 1.06x |
| 2025-05-21 | 1.15x |
| 2025-05-20 | 1.04x |
| 2025-05-19 | 0.93x |
| 2025-05-16 | 0.82x |
| 2025-05-15 | 0.82x |
| 2025-05-14 | 1.35x |
| 2025-05-13 | 1.56x |
| 2025-05-12 | 1.63x |
| 2025-05-09 | 1.50x |
| 2025-05-08 | 1.60x |
| 2025-05-07 | 1.47x |
| 2025-05-06 | 1.37x |
| 2025-05-05 | 1.71x |
| 2025-05-02 | 1.82x |
| 2025-05-01 | 1.75x |
| 2025-04-30 | 1.40x |
| 2025-04-29 | 1.28x |
| 2025-04-28 | 1.18x |
| 2025-04-25 | 1.13x |
| 2025-04-24 | 1.00x |
| 2025-04-23 | 1.48x |
| 2025-04-22 | 1.56x |
| 2025-04-21 | 1.37x |
| 2025-04-17 | 1.18x |
| 2025-04-16 | 1.12x |
| 2025-04-15 | 1.10x |
| 2025-04-14 | 1.21x |
| 2025-04-11 | 1.03x |
| 2025-04-10 | 0.97x |
| 2025-04-09 | 1.07x |
| 2025-04-08 | 0.96x |
| 2025-04-07 | 1.32x |
| 2025-04-04 | 1.36x |
| 2025-04-03 | 1.42x |
| 2025-04-02 | 1.70x |
| 2025-04-01 | 1.57x |
| 2025-03-31 | 2.46x |
| 2025-03-28 | 2.56x |
| 2025-03-27 | 2.52x |
| 2025-03-26 | 2.39x |
| 2025-03-25 | 2.62x |
| 2025-03-24 | 2.68x |
| 2025-03-21 | 2.49x |
Showing the most recent 260 of 294 data points. The chart above shows the full history.
